Cefotetan-Induced Hemolytic Anemia: Case Series and Review

Purpose: To raise awareness of cefotetan-induced hemolytic anemia, a known rare but serious side effect that occurred in 5 patients at our medical center. Summary: Five cases of cefotetan-induced hemolytic anemia, which presented over the period of a single year at our center, are described. In each...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmacy practice 2019-12, Vol.32 (6), p.679-682
Main Authors: Lim, Kathlyn, Tran, Hai, Hirai-Yang, Angela, Vakil, Niyati, Marks, Gregory, Klapper, Ellen
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Anemia, Hemolytic - chemically induced
Anti-Bacterial Agents - adverse effects
Cefotetan - adverse effects
Drug-Related Side Effects and Adverse Reactions
Female
Humans
Male
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose: To raise awareness of cefotetan-induced hemolytic anemia, a known rare but serious side effect that occurred in 5 patients at our medical center. Summary: Five cases of cefotetan-induced hemolytic anemia, which presented over the period of a single year at our center, are described. In each case, hemolytic anemia was confirmed by testing for the presence of anti-cefotetan antibodies. Each case occurred approximately 1 to 2 weeks following exposure to the drug. All five patients survived. A brief review of drug-induced immune hemolytic anemia (DIIHA) is also discussed. Conclusion: DIIHA may be difficult to distinguish from other causes of hemolytic anemia, but should be included in the differential in patients exposed to medications associated with DIIHA. Once suspected, antibody testing should be performed, and once diagnosed, further exposure should be avoided.
ISSN:0897-1900
1531-1937
DOI:10.1177/0897190018798198